Recent Material Events

Track the latest material events (8-K filings) with AI-powered analysis. Stay informed about major corporate developments, acquisitions, and changes.

📊 1313 Events

🤖 AI Analyzed

Recent

📄 Page 106 of 110

Emmaus Life Sciences, Inc.

8-K March 31, 2026

Key Highlights

First positive operating profit achieved through aggressive 34% cost reduction
Strategic pivot toward international markets in the Middle East and North Africa
Outsourced U.S. sales and logistics to NeoImmuneTech to lower overhead

Read Analysis

🤖 AI Generated

BIOGEN INC.

8-K March 31, 2026

Key Highlights

Strategic acquisition of Apellis Pharmaceuticals for $7.8 billion to enter the h...
Diversification beyond core neurology to mitigate patent expiration risks for fl...
Acquisition of SYFOVRE®, the first FDA-approved treatment for geographic atrophy...

Read Analysis

🤖 AI Generated

Aptose Biosciences Inc.

8-K March 31, 2026

Key Highlights

Shareholders approved acquisition by Hanmi Pharmaceutical
Cash payout of C$2.41 per share for investors
Positive clinical trial data for lead drug tuspetinib (TUS)

Read Analysis

🤖 AI Generated

BARRETT BUSINESS SERVICES INC

8-K March 31, 2026

Key Highlights

Core business operations, payroll, and PEO services remain unaffected by the rul...
The $12 million charge is a one-time event related to historical tax filings (20...
Management maintains a strong financial position, typically earning $20M–$30M pe...

Read Analysis

🤖 AI Generated

VOLITIONRX LTD

8-K March 31, 2026

Key Highlights

Revenue growth of 40% YoY to $1.7 million, with Q4 revenue jumping 133%.
Operating expenses reduced by 17% to $19.7 million, narrowing annual losses.
Active negotiations with 10 major diagnostic companies for Nucleosomics™ licensi...

Read Analysis

🤖 AI Generated

SANGAMO THERAPEUTICS, INC

8-K March 30, 2026

Key Highlights

Strategic pivot to a neurology-focused biotech model
Advancement of ST-920 for Fabry disease into late-stage testing
Proprietary 'zinc finger' gene-regulation technology platform

Read Analysis

🤖 AI Generated

Capstone Green Energy Holdings, Inc.

8-K March 30, 2026

Key Highlights

Secured $112.5 million in funding to stabilize finances and regain full operatio...
Achieved 100% ownership of the operating subsidiary, capturing 20–25% profit mar...
Strategic pivot toward profitability and operational efficiency under new board ...

Read Analysis

🤖 AI Generated

Invech Holdings, Inc.

8-K March 30, 2026

Key Highlights

Appointment of Alexander M. Woods-Leo as new CEO
Performance-based compensation structure tied to sales growth
Modernization of corporate bylaws and shareholder voting

Read Analysis

🤖 AI Generated

NextPlat Corp

8-K March 30, 2026

Key Highlights

Strategic 1-for-10 reverse stock split to maintain Nasdaq compliance
Focus on e-commerce and healthcare service revenue growth
Maintains operational continuity with no impact on business contracts

Read Analysis

🤖 AI Generated

Zivo Bioscience, Inc.

8-K March 30, 2026

Key Highlights

Strategic pivot to reduce operational costs by deregistering from the SEC
Focusing capital on core algal biomass and poultry gut health products
Transitioning to private-style operations to preserve cash reserves

Read Analysis

🤖 AI Generated

SPIRE INC

8-K March 30, 2026

Key Highlights

Transitioning to a 'pure-play' regulated utility model for increased stability.
Divestiture of Spire Marketing for $215 million in cash to reduce debt.
Strategic reinvestment into core utility infrastructure to drive rate-based grow...

Read Analysis

🤖 AI Generated

DYADIC INTERNATIONAL INC

8-K March 30, 2026

Key Highlights

Innovative C1-cell technology platform for vaccine and drug development
Active growth phase with potential for new licensing deals and partnerships
Clear regulatory roadmap provided by Nasdaq to regain compliance

Read Analysis

🤖 AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from material event filings with our AI-powered analysis. Track corporate developments, acquisitions, and strategic changes.

Back to Homepage